Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 10 de 10
Filter
1.
Clin Transplant ; 32(12): e13441, 2018 12.
Article in English | MEDLINE | ID: mdl-30387908

ABSTRACT

Prior studies demonstrate poor agreement among pathologists' interpretation of kidney biopsy slides. Reliability of representative images of these slides uploaded to the United Network of Organ Sharing (UNOS) web portal for clinician review has not been studied. We hypothesized high agreement among pathologists' image interpretation, since static images eliminate variation induced by viewing different areas of movable slides. To test our hypothesis, we compared the assessments of UNOS-uploaded images recorded in standardized forms by three pathologists. We selected 100 image sets, each having at least two images from kidneys of deceased donors. Weighted Cohen's kappa was used for inter-rater agreement. Mean (SD) donor age was 50 (13). Acute tubular injury had kappas of 0.12, 0.14, and 0.19; arteriolar hyalinosis 0.16, 0.27, and 0.38; interstitial inflammation 0.30, 0.33, and 0.49; interstitial fibrosis 0.28, 0.32, and 0.67; arterial intimal fibrosis 0.34, 0.42, and 0.59; tubular atrophy 0.35, 0.41, and 0.52; glomeruli thrombi 0.32, 0.53, and 0.85; and global glomerulosclerosis 0.68, 0.70, and 0.77. Pathologists' agreement demonstrated kappas of 0.12 to 0.77. The lower values raise concern about the reliability of using images. Although further research is needed to understand how uploaded images are used clinically, the field may consider higher-quality standards for biopsy photomicrographs.


Subject(s)
Databases, Factual , Image Processing, Computer-Assisted/methods , Kidney/pathology , Tissue Banks/organization & administration , Tissue Donors/supply & distribution , Tissue and Organ Procurement/standards , Biopsy , Female , Humans , Kidney/diagnostic imaging , Kidney Transplantation , Male , Middle Aged , Reproducibility of Results
2.
J Clin Transl Hepatol ; 5(2): 152-164, 2017 Jun 28.
Article in English | MEDLINE | ID: mdl-28660153

ABSTRACT

Vascular diseases of the spleen are relatively uncommon in the clinical practice. However, the reported incidence has been progressively increasing, probably due to advances in the imaging modalities used to detect them. This disease condition often presents with non-specific clinical manifestations, but can be associated with significant morbidity and mortality. This review article aims to provide updated clinical information on the different vascular diseases of the splenic vasculature-splenic vein thrombosis, splenic vein aneurysm, splenic artery aneurysm, splenic arteriovenous fistula, and spontaneous splenorenal shunt-in order to aid clinicians in early diagnosis and management.

3.
Conn Med ; 81(3): 153-156, 2017 Mar.
Article in English | MEDLINE | ID: mdl-29772157

ABSTRACT

Cardiacmyxomas arethemostcom- mon benign primary cardiac neoplasms, typically arising from the interatrial septum at the border of the fossa ovalis.'Ihey are generally divided into two anatomic types - ovoid and papillary myxomas -the latter ofwhich are less common but more frequently associated with embolic events. Despite their high embolic potential, however, widespread systemic and peripheral embolization, particularly to the lower extremities, is still uncommon. Furthermore, systemic tumor embolization secondary to trauma is only rarely reported and predominantly associ- ated with major blunt force trauma, such as motor vehicle accidents. Herein, we report a case of a 24-year-old male with widespread systemic and peripheral embolization of a left atrial myxoma, resulting in bilateral lower extremity ischemia, as well as multiple infarcts in major solid organs, in- cluding the heart, triggered by blunt chest trauma incurred during a basketball game.


Subject(s)
Embolization, Therapeutic , Heart Neoplasms/surgery , Myxoma/surgery , Thoracic Injuries/therapy , Wounds, Nonpenetrating/therapy , Heart Atria , Heart Neoplasms/complications , Humans , Male , Myxoma/complications , Thoracic Injuries/complications , Wounds, Nonpenetrating/complications , Young Adult
4.
Clin Imaging ; 39(4): 702-6, 2015.
Article in English | MEDLINE | ID: mdl-25748474

ABSTRACT

The authors report and discuss a rare case of a small vessel hepatic hemangioma in a 59-year-old patient with liver cirrhosis, which was pre-procedurally characterized as indeterminate due to atypical magnetic resonance imaging (MRI) features. This manuscript reviews the MRI features with pathologic correlation, emphasizes the importance of accurate characterization of liver lesions, and discusses the role of biopsy. We believe this is the first reported case of a small vessel hemangioma in liver cirrhosis with imaging and histopathologic correlation.


Subject(s)
Hemangioma/pathology , Liver Cirrhosis/pathology , Liver Neoplasms/pathology , Female , Hemangioma/complications , Humans , Liver Cirrhosis/complications , Liver Neoplasms/complications , Magnetic Resonance Imaging/methods , Middle Aged
5.
Fetal Pediatr Pathol ; 34(2): 108-16, 2015 Apr.
Article in English | MEDLINE | ID: mdl-25353700

ABSTRACT

This is a case report of an asymptomatic 4-year-old girl who was found to have a nodule at the lateral left lobe of the liver. She underwent transabdominal liver ultrasound and abdominal MRI that showed calcification and intense arterial enhancement but they failed to clearly exclude malignancy. The patient underwent an unremarkable laparoscopic wedge liver resection of the lesion because of its location and size. Pathological examination showed features compatible with a benign telangiectatic hyperplastic nodule with vascular malformation and calcification. CD34 immunostained the proliferative vascular lining cells while CK7 and CK19 highlighted the normal bile ducts present within the lesion. The diagnosis of a telangiectatic hyperplastic nodule associated with vascular malformation has been scarcely reported in children and our case shows for the first time that it can also present with calcifications.


Subject(s)
Liver Neoplasms/pathology , Liver Neoplasms/surgery , Vascular Malformations/pathology , Cell Proliferation/physiology , Child, Preschool , Female , Humans , Hyperplasia/diagnostic imaging , Hyperplasia/surgery , Liver Neoplasms/blood supply , Liver Neoplasms/diagnosis , Magnetic Resonance Imaging/methods , Treatment Outcome , Ultrasonography , Vascular Malformations/diagnosis
6.
Semin Liver Dis ; 34(2): 246-51, 2014 May.
Article in English | MEDLINE | ID: mdl-24879988

ABSTRACT

A 67-year-old woman with hypertension, hypothyroidism, and glaucoma was referred for jaundice and elevated liver function tests. She was treated for streptococcal endophthalmitis with 2 weeks of intravenous (IV) levofloxacin followed by 2 months of oral levofloxacin. The patient had no prior history of liver disease and denied alcohol intake. Her physical exam was remarkable for jaundice and scleral icterus without any stigmata of liver disease. Viral hepatitis serologies and antibodies, including myeloperoxidase, proteinase 3, and antinuclear, antimitochondrial, antiliver kidney microsome, antismooth muscle antibodies, were all within normal limits. The liver biopsy revealed severe cholestasis, extensive bile duct loss, and fibrosis. The patient had no known exposure to any other systemic medications or inciting factors other than levofloxacin. Although there are a few reported cases of drug-induced liver disease (DILI) related to levofloxacin, this case is believed to be the first reported case of ductopenia or vanishing bile duct syndrome (VBDS) associated with levofloxacin. Although fluoroquinolones, such as levofloxacin, are generally considered safe antibiotics, health practitioners must be aware of their association with DILI, as the diagnosis of DILI is one of exclusion and requires a high index of suspicion.


Subject(s)
Anti-Bacterial Agents/adverse effects , Bile Ducts/pathology , Chemical and Drug Induced Liver Injury/etiology , Chemical and Drug Induced Liver Injury/pathology , Cholestasis/chemically induced , Levofloxacin/adverse effects , Aged , Biopsy , Cholestasis/pathology , Female , Humans , Liver Cirrhosis/chemically induced , Liver Cirrhosis/pathology
7.
Semin Liver Dis ; 34(1): 108-12, 2014 Feb.
Article in English | MEDLINE | ID: mdl-24782264

ABSTRACT

Fibrosing cholestatic hepatitis is an unusual complication of hepatitis C virus (HCV) recurrence after liver transplant. Fibrosing cholestatic hepatitis is marked by aggressive progression of cholestasis and fibrosis, leading to accelerated graft loss and/or death. Sofosbuvir (GS-7977) is an oral nucleotide analogue inhibitor of HCV polymerase activity. It is a second-generation, direct-acting, antiviral for the treatment of HCV infection. This case illustrates a patient with recurrent HCV with fibrosing cholestatic hepatitis, who was successfully treated with a combination of sofosbuvir and ribavirin with normalization of liver enzyme activities and resolution of HCV-related symptoms. The favorable side effect profile and the lack of drug-drug interaction with immunosuppressive medications make the combination of sofosbuvir and ribavirin a promising regimen for severe HCV recurrence.


Subject(s)
Antiviral Agents/therapeutic use , Cholestasis, Intrahepatic/drug therapy , Hepatitis C, Chronic/drug therapy , Liver Cirrhosis, Alcoholic/surgery , Liver Cirrhosis/surgery , Liver Transplantation , Ribavirin/therapeutic use , Uridine Monophosphate/analogs & derivatives , Biopsy , Cholestasis, Intrahepatic/diagnosis , Cholestasis, Intrahepatic/virology , Drug Therapy, Combination , Hepatitis C, Chronic/complications , Hepatitis C, Chronic/diagnosis , Hepatitis C, Chronic/virology , Humans , Liver Cirrhosis/diagnosis , Liver Cirrhosis/virology , Liver Cirrhosis, Alcoholic/complications , Liver Cirrhosis, Alcoholic/diagnosis , Male , Middle Aged , Recurrence , Sofosbuvir , Treatment Outcome , Uridine Monophosphate/therapeutic use
8.
Pathol Res Pract ; 210(7): 402-6, 2014 Jul.
Article in English | MEDLINE | ID: mdl-24726263

ABSTRACT

BACKGROUND: A problem in the management of patients with Barrett's esophagus-related pT1 esophageal adenocarcinoma is to distinguish those who should be treated conservatively (endoscopic mucosal resection and/or radiofrequency ablation) from those who require esophago-gastrectomy. Recently, lymphovascular invasion (LVI) has emerged as one of the best predictors of regional lymph node metastasis (LNM) and recurrence-free survival (RFS) in pT1 EAC. However, LVI may be underestimated, both because of interobserver variability and incomplete sampling. The aim of our study was to correlate the presence of LVI, with the immunohistochemical expression of IMP3 in pT1 EAC and assess their role in further stratifying these lesions into high and low risk groups based on the potential for lymph node metastasis and poor outcome. DESIGN: Depth of invasion, assessed in five sublevels (m2, m3, sm1, sm2, and sm3), LVI, and expression of IMP3 were studied in 30 patients who underwent esophagogastrectomy for pT1 EAC (2001-2010) at Hartford Hospital, and correlated with LNM and RFS. IMP3 was considered positive when expressed in >50% of the malignant cells with an intensity of stain of 2-3+. RESULTS: Ten of 18 (55.5%) cases with IMP3 expression demonstrated LVI and 2/10 (20%) showed LNM and died of disease. In contrast, none of the 12 IMP3 negative cases showed LVI (p<0.004; 2-tailed Fisher exact test) or had LNM/DOD. CONCLUSIONS: In pT1 EAC, (1) based on IMP3 expression, pT1 EAC may be divided into high risk (LVI+/IMP3+) and low risk (LVI-/IMP3-) categories. (2) Absence of IMP3 expression is associated with a significantly reduced risk of LVI (Negative Predictive Value: 100%). (3) Since identifying lymphovascular invasion and other morphological parameters is prone to significant inter-observer variation, IMP3 may be useful as an ancillary marker especially in these pT1 lesions in predicting their clinical behavior, the risk stratification and potentially on the type of treatment.


Subject(s)
Adenocarcinoma/pathology , Biomarkers, Tumor/analysis , Esophageal Neoplasms/pathology , Lymphatic Metastasis/pathology , RNA-Binding Proteins/metabolism , Adult , Aged , Aged, 80 and over , Female , Humans , Immunohistochemistry , Male , Middle Aged , Neoplasm Invasiveness/pathology , Neoplasm Staging , Predictive Value of Tests , Prognosis
9.
Arch Pathol Lab Med ; 137(2): 284-8, 2013 Feb.
Article in English | MEDLINE | ID: mdl-23368873

ABSTRACT

We report a case of microcystic/reticular schwannoma of the proximal sigmoid colon in a 61-year-old man. A 12-mm polyp was detected while the patient was undergoing screening for colorectal neoplasm. This rare variant of schwannoma was initially described in 2008 and shows a predilection for the visceral organs, predominantly the gastrointestinal tract. We also review 11 other reported cases of microcystic/reticular schwannomas in the gastrointestinal tract. Unlike conventional gastrointestinal schwannomas, which are more common in the stomach, this variant appears to be more common in the large intestine. Histologic examination of this polyp showed predominant lipoblast-like vacuolated cells within a myxoid stroma with focal spindle cell areas. Features suggestive of malignancy, like nuclear pleomorphism, mitosis, or necrosis, were absent. Immunohistochemistry for S100 protein showed strong nuclear and cytoplasmic positivity, whereas cytokeratin and CD117 stains were negative. It is important to entertain microcystic/reticular schwannoma in the differential diagnosis of a signet ring cell adenocarcinoma or a myxoid gastrointestinal stromal tumor, particularly on small biopsy specimens.


Subject(s)
Colonic Neoplasms/pathology , Neurilemmoma/pathology , Calgranulin A/metabolism , Carcinoma, Signet Ring Cell/diagnosis , Colonic Neoplasms/diagnosis , Colonic Neoplasms/metabolism , Diagnosis, Differential , Gastrointestinal Stromal Tumors/diagnosis , Humans , Immunohistochemistry , Keratins/metabolism , Male , Microscopy, Electron, Transmission , Middle Aged , Neurilemmoma/diagnosis , Neurilemmoma/metabolism , Proto-Oncogene Proteins c-kit/metabolism
10.
J Gastrointest Oncol ; 3(2): 139-42, 2012 Jun.
Article in English | MEDLINE | ID: mdl-22811881

ABSTRACT

Hepatoid adenocarcinoma is an alpha-fetoprotein producing adenocarcinoma arising in numerous extra-hepatic organs. The diagnosis may be difficult because of the varied presentation but immunohistochemistries help make the diagnosis. The prognosis is often poor but in this report, we present a young female with hepatoid carcinoma who is doing well more than three years after her diagnosis.

SELECTION OF CITATIONS
SEARCH DETAIL
...